| 产品名称 | ABT 702 |
| 产品货号 | Axon 2289 CAS [214697-26-4] MF C22H19BrN6OMW 463.33 Purity: 99% Soluble in 0.1N HCl(aq) and DMSO Description The first, non-nucleoside adenosine kinase (ADK) inhibitor (IC50 value 2 nM and 50 nM in cytosolic and intact cell assays, respectively). ABT702 is orally active to reduce pain and inflammation in animal models, yet found to be clastogenic in an in vitro Chinese Hamster micronucleus assay. KEYWORDS: ABT 702 | supplier | ADK inhibitor | ABT702 | CAS [214697-26-4] | ATP | ADK | pain | inflammation | clastogenic | mutagenesis |
| 产品价格 | 现货询价，电话：010-67529703 |
| 产品规格 | |
| 产品品牌 | axonmedchem |
| 产品概述 | |
| 产品详情 |
ABT 702Axon 2289 CAS [214697-26-4] MF C22H19BrN6O
DescriptionThe first, non-nucleoside adenosine kinase (ADK) inhibitor (IC50 value 2 nM and 50 nM in cytosolic and intact cell assays, respectively). ABT702 is orally active to reduce pain and inflammation in animal models, yet found to be clastogenic in an in vitro Chinese Hamster micronucleus assay. KEYWORDS: ABT 702 | supplier | ADK inhibitor | ABT702 | CAS [214697-26-4] | ATP | ADK | pain | inflammation | clastogenic | mutagenesis
The first, non-nucleoside adenosine kinase (ADK) inhibitor
Chemical name5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2,3-d]pyrimidin-4-amine Parent CAS No.[214697-26-4] |
| 产品资料 |
